[안내 사항]

안녕하십니까? 코아스템 입니다.

금일 오후 공시를 통해 전해 드린' 주주 총회 소집 공고'와 '주식 매수청구권 행사' 안내와 관련하여

내용을 확인하지 못하신 분들이 있을 수 있기에 본 내용을 홈페이지 공지사항를 통해

다시 한번 전해 드립니다.

또한 주식매수청구권 행사 안내 내용에는 주식매수 청구를 위한 양식을 다운 받을 수 있기에

이점 참고를 부탁드립니다.

감사합니다.
   
  • A WARM COMPANION FOR YOU EXHAUSTED

    Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.

SCROLL

Products

We are dedicated to developing and advancing new therapies that improve the quality of life of patients suffering from intractable and rare diseases.

SEE MORE

Lou Gehrig’s Disease

Based on our experience in the development and commercialization of ALS stem cell therapies, we develop therapeutic agents for rare and intractable diseases.

SEE MORE

NEURONATA-R®

Autologous Mesenchymal Stem Cell

We have been eagerly challenging our research and development to fulfill the unmet needs for patients who have waited for years for treatment

SEE MORE

Clinical Process

Corestem is an innovative company that integrates scientific expertise, creativity, and cutting-edge technology, and is opening a new era of personalized medical care.
  • STEP 1

    Discovery

    Screening and identifying candidates for disease areas and therapeutic purposes

  • STEP 2

    Pre-clinical

    Collecting the important feasibility, iterative testing and drug safety data from in vitro and in vivo

  • STEP 3

    Clinical

    Generating data on safety and efficacy in human

  • STEP 4

    Registration

    Permission through safety, efficacy, standards and test methods, drug manufacturing and quality control assessment

R&D CENTER

BIO PHARMACEUTICAL
COMPANY

We have focused on R&D for stem cell therapies in rare and incurable disease, promoting scientific progress, and expanding our knowledge of disease for patients.

SEE MORE

Investor

Creating maximized value through strategic R&D in intractable disease

STOCK INFORMATION

Creating maximized value through strategic R&D in intractable disease

Real-Time Quotes
▲9,390 WON
Change 160 ▲
Chg(%)+1.73 %